Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5T

被引:70
作者
Baik, Hyun-Man
Su, Min-Ying
Yu, Hon
Mehta, Rita
Nalcioglu, Orhan
机构
[1] Univ Calif Irvine, John Tu & Thomas Ctr Funct Oncoimaging, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA
关键词
choline; breast cancer; proton magnetic resonance spectroscopy; quantification;
D O I
10.1007/s10334-006-0032-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The quantification of choline-containing compounds (Cho) in breast tumors by proton MR spectroscopy (H-1-MRS) has been of great interest because such compounds have been linked to malignancy. In this study, an internal reference method for the absolute quantification of Cho metabolite in malignant breast tumors was presented using a clinical 1.5 T scanner. We performed in vitro measurements to examine the accuracy of absolute quantification using four phantoms of known choline chloride concentrations. There was a high correlation between the calculated concentrations by MRS and the known concentrations (r(2) > 0.98). We applied the technique to in vivo breast study conducted on 45 patients with biopsy-confirmed breast cancer. After T-1 and T-2 relaxation times were corrected, the Cho levels in this work had a range of 0.76 - 21.20 mmol/kg from 34 MR spectra of 32 patients with malignant breast lesions. This result was rather consistent with the previously published value (i.e., 1.38 10 mmol/kg, Bolan et al. in Magn Reson Med 50:1134-1143, 2003). Therefore, we conclude that the internal method using the fully relaxed water as a reference could be used for quantifying Cho metabolite accurately in breast cancer patients using a clinical 1.5 T scanner.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 35 条
[1]  
Aboagye EO, 1999, CANCER RES, V59, P80
[2]   External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla [J].
Bakken, IJ ;
Gribbestad, IS ;
Singstad, TE ;
Kvistad, KA .
MAGNETIC RESONANCE IN MEDICINE, 2001, 46 (01) :189-192
[3]   In vivo quantification of choline compounds in the breast with 1H MR spectroscopy [J].
Bolan, PJ ;
Meisamy, S ;
Baker, EH ;
Lin, J ;
Emory, T ;
Nelson, M ;
Everson, LI ;
Yee, D ;
Garwood, M .
MAGNETIC RESONANCE IN MEDICINE, 2003, 50 (06) :1134-1143
[4]   SPATIAL LOCALIZATION IN NMR-SPECTROSCOPY INVIVO [J].
BOTTOMLEY, PA .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 508 :333-348
[5]   The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy [J].
Cecil, KM ;
Schnall, MD ;
Siegelman, ES ;
Lenkinski, RE .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 68 (01) :45-54
[6]   Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy [J].
Cheng, LL ;
Chang, IW ;
Smith, BL ;
Gonzalez, RG .
JOURNAL OF MAGNETIC RESONANCE, 1998, 135 (01) :194-202
[7]   WATER SIGNAL ELIMINATION INVIVO, USING SUPPRESSION BY MISTIMED ECHO AND REPETITIVE GRADIENT EPISODES [J].
DODDRELL, DM ;
GALLOWAY, GJ ;
BROOKS, WM ;
FIELD, J ;
BULSING, JM ;
IRVING, MG ;
BADDELEY, H .
JOURNAL OF MAGNETIC RESONANCE, 1986, 70 (01) :176-180
[8]   H-1-NMR SPECTROSCOPIC CHARACTERIZATION OF PERCHLORIC-ACID EXTRACTS FROM BREAST CARCINOMAS AND NONINVOLVED BREAST-TISSUE [J].
GRIBBESTAD, IS ;
PETERSEN, SB ;
FJOSNE, HE ;
KVINNSLAND, S ;
KRANE, J .
NMR IN BIOMEDICINE, 1994, 7 (04) :181-194
[9]  
GRIBBESTAD IS, 1993, ANTICANCER RES, V13, P1973
[10]  
Gribbestad IS, 1999, ANTICANCER RES, V19, P1737